share_log

BTIG Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $16

BTIG Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $16

BTIG以買入評級啓動ProKidny的保險,宣佈目標股價爲16美元
Benzinga ·  2023/07/25 04:32

BTIG analyst Justin Zelin initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $16.

BTIG分析師賈斯汀·澤林在ProKidney(納斯達克:PROK)上以買入評級啟動報道,並宣佈目標價為16美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論